Millennials' medspa influence

Jun 24, 2008

[B]Women ages 18-34 are empowering the medical spa trend but doing little to advocate their own safety within the facility[/B]
The American Academy of Cosmetic Surgery has released its results from a consumer survey asking 1,000 women their opinions on medical spas. Findings revealed that millennials, those born between 1976 and 2001, are the primary customers of these facilities. Yet half of those women are compromising their safety by visiting a non-physician supervised medspa facility.

Women ages 18-34 were more than three times as likely as women ages 35-64 to have had a non-invasive cosmetic procedure such as Botox performed at a medspa. On the flip side, from 2002 to 2007, the mean age of patients seeking the top ten most performed invasive procedures has increased by two years, making the baby boomers the driving force of liposuction and face lifts. "What is going on here is that the younger the patient, the more likely they are to visit a medspa in order to receive a non-invasive procedure like Botox," said AACS President Steven Hopping, MD, FACS.

Moreover, the survey confirms that the younger patients are more lax when it comes to safety at a medspa. Two-thirds of the women surveyed indicated that they would hope to be treated by a physician when visiting a medspa. However, among women who had an opinion, more than half (52.3%) indicated they would be comfortable if the physician were not present during a non-invasive cosmetic procedure performed at a medspa.

"This consumer survey is a chance to once again emphasize the importance of patient safety, and to educate the public on these facilities," said Dr. Hopping. "There are good and bad medspas out there and we want the public to be aware, ask questions and always make sure there is a qualified physician doing the procedure. If not, don't have it done."

Source: American Academy of Cosmetic Surgery

Explore further: Novartis reports Q1 profit up on divestitures

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Novartis reports Q1 profit up on divestitures

19 minutes ago

Swiss pharmaceutical company Novartis AG has reported a 24 percent increase in profit for the first quarter, helped by selling off less-profitable parts of its business.

Amgen misses 1Q views as higher costs cut profit

Apr 22, 2014

Despite higher sales, biotech drugmaker Amgen's first-quarter profit fell 25 percent as production and research costs rose sharply, while the year-ago quarter enjoyed a tax benefit. The company badly missed ...

Valeant, Ackman make $45.6B Allergan bid

Apr 22, 2014

Valeant Pharmaceuticals and activist investor Bill Ackman have unveiled details of their offer to buy Botox maker Allergan, proposing a cash-and-stock deal that could be worth about $45.6 billion.

User comments : 0

More news stories

FDA proposes first regulations for e-cigarettes

The federal government wants to prohibit sales of electronic cigarettes to minors and require approval for new products and health warning labels under regulations being proposed by the Food and Drug Administration.

Vermont moves toward labeling of GMO foods

Vermont lawmakers have passed the country's first state bill to require the labeling of genetically modified foods as such, setting up a war between the behemoth U.S. food industry and an American public that overwhelmingly ...

Brazil enacts Internet 'Bill of Rights'

Brazil's president signed into law on Wednesday a "Bill of Rights" for the digital age that aims to protect online privacy and promote the Internet as a public utility by barring telecommunications companies ...